WinstonWınston
Back
Coloplast A/S logo

Coloplast A/S

CLPBY
64
Medical - Instruments & Supplies · Healthcare
Price
$6.88
+0.06 (+0.88%)
Market Cap
$15.51B
Exchange
Other OTC
Winston Score
64
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Weak
Cash Flow
Exceptional
Stability
Good
Valuation
Good
Dividends
Exceptional

Share count rising — dilution

+5.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.13B (2021) → 2.25B (2025)

Winston Score History

The full picture

Coloplast is a Danish medical device company that makes products for people with intimate health conditions — things like ostomy bags (for people who've had bowel surgery), catheters, wound care supplies, and continence products. Its customers are mostly patients, hospitals, and home care providers across the world. Coloplast is one of the largest companies globally focused specifically on these types of sensitive, chronic-care medical needs.

The company earns money by selling its medical supplies directly and through healthcare distributors, with many patients relying on its products on a recurring, long-term basis — which creates steady, repeat revenue. Coloplast operates in over 40 countries, with strong positions in Europe and growing sales in North America and emerging markets. Its moat comes from deep clinical relationships, specialized product design, and the fact that patients rarely switch brands once they find something that works. The main risk is pricing pressure from government healthcare systems and competition from lower-cost rivals in key markets.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
66.7%
Premium pricing power — 66.7% gross margin
Profit after running costs
Operating Margin
25.9%
Excellent — 25.9% operating margin
Return on the money invested
ROCE
20.6%
Exceptional — 20.6% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-2.9%
Shrinking sales (-2.9% YoY)
Profit growth
EPS YoY
-33.1%
Earnings shrinking (-33.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
281%
Turns 281% of profit into real cash
Spare cash per sale
FCF Margin
23.3%
Converts sales into free cash efficiently (23.3%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.73
Elevated debt (1.73)
Covers its interest
Interest Cover
11.05x
Comfortably covers interest (11.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
35.8x
Pricey — P/E 35.8

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+21.0
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (35.8 → 14.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
5.26%
Healthy income — 5.26% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+14.3%
Dividend growing fast (14.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial